NPPA fixes retail prices of formulations under Drugs (Prices Control) Order, 2013

Jun 03, 2019 | by Avantis RegTech Legal Research Team


The National Pharmaceutical Pricing Authority (NPPA) on May 31, 2019, has passed an Order in order to fix the retail prices of formulations under the Drugs (Prices Control) Order, 2013. 

The names of the formulations are:

1) Alpha Lipoic + Methylcobalamin + Inositol USP + Folic Acid + Benfotiamine + Chromium Polynicotinate + Pyridoxine Hydrochloride Capsule

2) Voveran 1ml AQ Injection

3) Diclofenac + Thiocolchicoside Capsule

4) Amoxycillin + Clavulanic Acid Tablet (UNIMOX CV 1000)

5) Glimepiride + Metformin + Voglibose Tablet

6) Erythropoietin + Human Albumin + Sodium Chloride + Sodium Phosphate +Sodium Dihydrogen Phosphate Monohydrate Injection (Repoitin 40000)

7) Amlodipine + Metoprolol Tablet (Amlosafe MT 25mg)

8) Rabeprazole + Domperidone Capsule (Instek D Capsule)

9) Pantoprazole + Domperidone Capsule (Domelong P Capsule)

10) Metformin + Voglibose Tablet (Proglutrol V 0.3)

11) Metformin + Glimepiride Tablet (Proglutrol G1, G2) (Proglutrol G1 Forte, Proglutrol G2 Forte)

12) Pantoprazole Sodium + Itopride Hydrochloride Capsules (PANZO-IT)

13) Atorvastatin Tablet (TORVASON -80)


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.